Page last updated: 2024-11-05

tizanidine and Chronic Disease

tizanidine has been researched along with Chronic Disease in 16 studies

tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"The efficacy of the modified-release formulation of tizanidine (Sirdalud) was compared with placebo in a randomized, double-blind, parallel-group study of 138 women and 47 men, aged 18 to 79 years, with a history of chronic tension-type headache (IHS categories 2."9.09Modified-release formulation of tizanidine in chronic tension-type headache. ( Färkkilä, M; Havanka, H; Hedman, C; Kataja, M; Keränen, T; Murros, K; Peltola, J; Säkö, E, 2000)
"The efficacy of tizanidine in chronic tension-type headache was compared with placebo in a randomized, double-blind and cross-over study in 37 women aged 20 to 59 years with a history of headache for 7 months to 30 years (median 5 years)."9.07Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study. ( Fogelholm, R; Murros, K, 1992)
"A double-blind trial with two parallel groups was carried out to compare the antispastic effect and tolerability of a new muscle relaxant, tizanidine (DS 103-282), with those of baclofen in the treatment of spasticity due to multiple sclerosis."9.05A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis. ( Muff, S; Smolenski, C; Smolenski-Kautz, S, 1981)
"The efficacy of the modified-release formulation of tizanidine (Sirdalud) was compared with placebo in a randomized, double-blind, parallel-group study of 138 women and 47 men, aged 18 to 79 years, with a history of chronic tension-type headache (IHS categories 2."5.09Modified-release formulation of tizanidine in chronic tension-type headache. ( Färkkilä, M; Havanka, H; Hedman, C; Kataja, M; Keränen, T; Murros, K; Peltola, J; Säkö, E, 2000)
"The efficacy of tizanidine in chronic tension-type headache was compared with placebo in a randomized, double-blind and cross-over study in 37 women aged 20 to 59 years with a history of headache for 7 months to 30 years (median 5 years)."5.07Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study. ( Fogelholm, R; Murros, K, 1992)
"A double-blind trial with two parallel groups was carried out to compare the antispastic effect and tolerability of a new muscle relaxant, tizanidine (DS 103-282), with those of baclofen in the treatment of spasticity due to multiple sclerosis."5.05A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis. ( Muff, S; Smolenski, C; Smolenski-Kautz, S, 1981)
" The first group was used as control group (Control) (n = 20), in the second group subarachnoid hemorrhage was performed (SAH) (n = 20), in the third group Tizanidine was administered in addition to SAH (SAH + Tizanidine administration) (n = 20)."3.70The effect of tizanidine on chronic vasospasm in rats. ( Berkman, MK; Berkman, MZ; Erbengi, T; Iplikçioğlu, AC; San, T; Sav, A, 2000)
"The antinociceptive actions of morphine and tizanidine (an alpha 2-adrenergic agonist) administered intrathecally in a rat model of mononeuropathic pain were investigated."3.69A comparison of intrathecally administered narcotic and nonnarcotic analgesics for experimental chronic neuropathic pain. ( Dills, CV; Kim, DL; Leiphart, JW; Levy, RM; Zikel, OM, 1995)
"Tizanidine is an alpha2-adrenergic agonist that inhibits the release of norepinephrine at both the spinal cord and brain, with antinociceptive effects that are independent of the endogenous opioid system."2.70Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. ( Cantrell, DT; Lake, AE; Saper, JR; White, JR; Winner, PK, 2002)
"Chronic migraine is an important public health problem."1.36Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials. ( D'Amico, D, 2010)
"Tizanidine (TZD) is an alpha-2-adrenergic drug with potential spinal analgesic action and could be a substitute or additive for intrathecal (i."1.30Distribution, tolerability and tissue compatibility of intrathecal tizanidine in the sheep. ( Loew, M; Ochs, G; Tonn, J; Toyka, K, 1998)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.25)18.7374
1990's6 (37.50)18.2507
2000's6 (37.50)29.6817
2010's3 (18.75)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duffell, LD1
Brown, GL1
Mirbagheri, MM1
D'Amico, D1
Fuchigami, T1
Kakinohana, O1
Hefferan, MP1
Lukacova, N1
Marsala, S1
Platoshyn, O1
Sugahara, K1
Yaksh, TL1
Marsala, M1
Saper, JR1
Lake, AE1
Cantrell, DT1
Winner, PK1
White, JR1
Moufarrege, G1
Frank, E1
Carstens, DD1
Bettucci, D1
Testa, L1
Calzoni, S1
Mantegazza, P1
Viana, M1
Monaco, F1
Smolenski, C1
Muff, S1
Smolenski-Kautz, S1
Iakhno, NN1
Damulin, IV1
Chernenko, OA1
Ianakaeva, TA1
Kondrat'eva, ON1
Kur'ianova, PT1
Leiphart, JW1
Dills, CV1
Zikel, OM1
Kim, DL1
Levy, RM1
Vorobeĭchik, IaM1
Kukushkin, ML1
Reshetniak, VK1
Ovechkin, AM1
Gnezdilov, AV1
Filatova, EG1
Solov'eva, AD1
Danilov, AB1
Ochs, G1
Loew, M1
Tonn, J1
Toyka, K1
Murros, K2
Kataja, M1
Hedman, C1
Havanka, H1
Säkö, E1
Färkkilä, M1
Peltola, J1
Keränen, T1
Berkman, MZ1
Iplikçioğlu, AC1
Berkman, MK1
Erbengi, T1
San, T1
Sav, A1
Smith, TR1
Fogelholm, R1

Trials

8 trials available for tizanidine and Chronic Disease

ArticleYear
Interventions to Reduce Spasticity and Improve Function in People With Chronic Incomplete Spinal Cord Injury: Distinctions Revealed by Different Analytical Methods.
    Neurorehabilitation and neural repair, 2015, Volume: 29, Issue:6

    Topics: Analysis of Variance; Cervical Vertebrae; Chronic Disease; Clonidine; Data Interpretation, Statistic

2015
Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.
    Headache, 2002, Volume: 42, Issue:6

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Chronic Disease; Clonidine; Double-Blind Method; Femal

2002
Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life.
    The journal of headache and pain, 2006, Volume: 7, Issue:1

    Topics: Adult; Amitriptyline; Analgesics; Chronic Disease; Clonidine; Drug Therapy, Combination; Female; Hea

2006
A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Current medical research and opinion, 1981, Volume: 7, Issue:6

    Topics: Adult; Aged; Baclofen; Chronic Disease; Clinical Trials as Topic; Clonidine; Double-Blind Method; Fe

1981
[The efficacy of sirdalud in the drug therapy of pain in the spine].
    Terapevticheskii arkhiv, 1994, Volume: 66, Issue:10

    Topics: Acute Disease; Adult; Aged; Analgesics; Back Pain; Chronic Disease; Clonidine; Female; Humans; Male;

1994
[The treatment of the phantom pain syndrome with tizanidine].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1997, Volume: 97, Issue:3

    Topics: Adult; Aged; Analgesics; Chronic Disease; Clonidine; Double-Blind Method; Female; Humans; Male; Midd

1997
Modified-release formulation of tizanidine in chronic tension-type headache.
    Headache, 2000, Volume: 40, Issue:8

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Chronic Disease; Clonidine; Delayed-Action Preparations; Dou

2000
Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study.
    Headache, 1992, Volume: 32, Issue:10

    Topics: Adult; Analgesics; Chronic Disease; Clonidine; Depression; Dose-Response Relationship, Drug; Double-

1992

Other Studies

8 other studies available for tizanidine and Chronic Disease

ArticleYear
Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31 Suppl 1

    Topics: Amines; Analgesics; Chronic Disease; Clonidine; Cyclohexanecarboxylic Acids; Diagnosis, Differential

2010
Potent suppression of stretch reflex activity after systemic or spinal delivery of tizanidine in rats with spinal ischemia-induced chronic spastic paraplegia.
    Neuroscience, 2011, Oct-27, Volume: 194

    Topics: Animals; Chronic Disease; Clonidine; Disease Models, Animal; Male; Muscle Relaxants, Central; Neural

2011
Eosinophilic exudative pleural effusion after initiation of tizanidine treatment: a case report.
    Pain medicine (Malden, Mass.), 2003, Volume: 4, Issue:1

    Topics: Adult; Analgesics; Chronic Disease; Clonidine; Eosinophilia; Humans; Low Back Pain; Male; Pleural Ef

2003
A comparison of intrathecally administered narcotic and nonnarcotic analgesics for experimental chronic neuropathic pain.
    Journal of neurosurgery, 1995, Volume: 82, Issue:4

    Topics: Analgesics; Animals; Chronic Disease; Clonidine; Dose-Response Relationship, Drug; Humans; Injection

1995
[The treatment of tension headache with sirdalud].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1997, Volume: 97, Issue:11

    Topics: Adult; Chronic Disease; Clonidine; Drug Evaluation; Female; Humans; Male; Muscle Relaxants, Central;

1997
Distribution, tolerability and tissue compatibility of intrathecal tizanidine in the sheep.
    Acta anaesthesiologica Scandinavica, 1998, Volume: 42, Issue:7

    Topics: Adrenergic alpha-Agonists; Analgesia, Epidural; Analgesics; Analgesics, Opioid; Animals; Behavior, A

1998
The effect of tizanidine on chronic vasospasm in rats.
    Acta neurochirurgica, 2000, Volume: 142, Issue:9

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Chronic Disease; Clonidine; Disease Models, Animal; F

2000
Low-dose tizanidine with nonsteroidal anti-inflammatory drugs for detoxification from analgesic rebound headache.
    Headache, 2002, Volume: 42, Issue:3

    Topics: Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Clonidine; Dose-R

2002